Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: |
Title | NemaGen |
Description | we are nemagen Home About Technology Team News Careers Contact More Home About Technology Team News Careers Contact Home About Technology Team News Careers Contact we ar |
Keywords | N/A |
WebSite | nemagen.com |
Host IP | 13.248.243.5 |
Location | United States |
Site | Rank |
US$1,737
Last updated: 2023-05-19 11:31:43
nemagen.com has Semrush global rank of 0. nemagen.com has an estimated worth of US$ 1,737, based on its estimated Ads revenue. nemagen.com receives approximately 200 unique visitors each day. Its web server is located in United States, with IP address 13.248.243.5. According to SiteAdvisor, nemagen.com is safe to visit. |
Purchase/Sale Value | US$1,737 |
Daily Ads Revenue | US$1 |
Monthly Ads Revenue | US$48 |
Yearly Ads Revenue | US$577 |
Daily Unique Visitors | 13 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
nemagen.com. | A | 3598 | IP: 13.248.243.5 |
nemagen.com. | A | 3598 | IP: 76.223.105.230 |
nemagen.com. | NS | 3600 | NS Record: ns51.domaincontrol.com. |
nemagen.com. | NS | 3600 | NS Record: ns52.domaincontrol.com. |
nemagen.com. | MX | 3600 | MX Record: 0 nemagen-com.mail.protection.outlook.com. |
nemagen.com. | TXT | 3600 | TXT Record: NETORGFT5548141.onmicrosoft.com |
nemagen.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
Home About Technology Team News Careers Contact More Home About Technology Team News Careers Contact Home About Technology Team News Careers Contact we are nemagen discoveries NemaGen Discoveries is an early phase biotech company focused on advancing therapies for patients suffering from allergic inflammation and mast cell-related diseases. Our Science NemaGen’s novel technologies were developed by investigating the body’s natural ability to prevent unwanted inflammation following parasitic infections. By taking this unique approach NemaGen has pioneered new therapeutic strategies to help patients suffering from diverse inflammatory diseases. See More Latest News NemaGen to participate in NIH I-Corps To further support our drug development, NemaGen will be participating in the NIH I-Corps program March-April 2023 to speak with various stakeholders to better understand their needs and validate our therapy’s value. Read More Connect with us Contact Us Please email us for more |
HTTP/1.1 301 Moved Permanently location: https://nemagen.com/ vary: Accept-Encoding server: DPS/2.0.0-beta+sha-d6b9503 x-version: d6b9503 x-siteid: eu-central-1 set-cookie: dps_site_id=eu-central-1; path=/ etag: e7d30abde29dd07c27b699ee02e05c78 date: Sun, 02 Oct 2022 08:20:03 GMT keep-alive: timeout=5 HTTP/2 200 cache-control: max-age=30 content-security-policy: frame-ancestors 'self' godaddy.com *.godaddy.com content-type: text/html;charset=utf-8 vary: Accept-Encoding server: DPS/2.0.0-beta+sha-d6b9503 x-version: d6b9503 x-siteid: eu-central-1 set-cookie: dps_site_id=eu-central-1; path=/; secure etag: e7d30abde29dd07c27b699ee02e05c78 date: Sun, 02 Oct 2022 08:20:03 GMT |
Domain Name: NEMAGEN.COM Registry Domain ID: 2431664833_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2019-09-09T20:17:20Z Creation Date: 2019-09-09T20:17:19Z Registry Expiry Date: 2024-09-09T20:17:19Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2022-10-02T08:18:11Z <<< |